Raja Gopoju

Uppal Road
Hyderabad, TG 500007, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Hepatic SEC16B regulates lipid homeostasis by coordinating VLDL secretion and lipid droplet expansion.

Hepatic SEC16B regulates lipid homeostasis by coordinating VLDL secretion and lipid droplet expansion.

Journal: The Journal of clinical investigation

Published: January 13, 2026

Loss of Hepatocyte FOXA3 Improves MASH and Atherosclerosis in Hyperlipidemic Ldlr-Deficient Mice.

Loss of Hepatocyte FOXA3 Improves MASH and Atherosclerosis in Hyperlipidemic Ldlr-Deficient Mice.

Journal: International journal of molecular sciences

Published: January 07, 2026

Genetic or pharmacological inhibition of hepatic TMEM141 attenuates MASH and fibrosis via the ROS-HNF4α signaling pathway.

Genetic or pharmacological inhibition of hepatic TMEM141 attenuates MASH and fibrosis via the ROS-HNF4α signaling pathway.

Journal: Nature communications

Published: June 23, 2025

Loss of hepatic carboxylesterase 3 prevents the development of MASLD in mice.

Loss of hepatic carboxylesterase 3 prevents the development of MASLD in mice.

Journal: Journal of lipid research

Published: April 25, 2025

Loss of adipose ATF3 promotes adipose tissue lipolysis and the development of MASH.

Loss of adipose ATF3 promotes adipose tissue lipolysis and the development of MASH.

Journal: Communications biology

Published: May 29, 2024

Krüppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4α-mediated metabolic pathways.

Krüppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4α-mediated metabolic pathways.

Journal: Metabolism: clinical and experimental

Published: January 04, 2024

Hepatic FOXA3 overexpression prevents Western diet-induced obesity and MASH through TGR5.

Hepatic FOXA3 overexpression prevents Western diet-induced obesity and MASH through TGR5.

Journal: Journal of lipid research

Published: December 09, 2023

Hepatocyte Sirtuin 6 Protects against Atherosclerosis and Steatohepatitis by Regulating Lipid Homeostasis.

Hepatocyte Sirtuin 6 Protects against Atherosclerosis and Steatohepatitis by Regulating Lipid Homeostasis.

Journal: Cells

Published: June 13, 2023

Adipocyte retinoic acid receptor α prevents obesity and steatohepatitis by regulating energy expenditure and lipogenesis.

Adipocyte retinoic acid receptor α prevents obesity and steatohepatitis by regulating energy expenditure and lipogenesis.

Journal: Obesity (Silver Spring, Md.)

Published: May 23, 2023

Retinoic Acid Receptor Alpha (RARα) in Macrophages Protects from Diet-Induced Atherosclerosis in Mice.

Retinoic Acid Receptor Alpha (RARα) in Macrophages Protects from Diet-Induced Atherosclerosis in Mice.

Journal: Cells

Published: September 14, 2022

Hepatic retinoic acid receptor alpha mediates all-trans retinoic acid's effect on diet-induced hepatosteatosis.

Hepatic retinoic acid receptor alpha mediates all-trans retinoic acid's effect on diet-induced hepatosteatosis.

Journal: Hepatology communications

Published: February 22, 2022

Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).

Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).

Journal: Hepatology (Baltimore, Md.)

Published: April 01, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026